Alkido Pharma Inc (AIKI) |
|
1.2998 -0.02 (-1.53%)
|
02-25 12:15 |
|
Open: |
1.329 |
Pre. Close: |
1.32 |
|
High:
|
1.42 |
Low:
|
1.27 |
|
Volume:
|
14,167,665 |
Market Cap:
|
45M |
|
|
|
|
Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.442 - 1.45 |
1.45 - 1.458 |
|
Low:
|
1.251 - 1.26 |
1.26 - 1.269 |
|
Close:
|
1.306 - 1.32 |
1.32 - 1.333 |
|
Technical analysis |
as of: 2021-02-25 11:41:43 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.32 One year: 2.98 |
| Support: |
Support1: 1.07 Support2: 0.89 |
| Resistance: |
Resistance1: 1.98 Resistance2: 2.55 |
| Pivot: |
1.64  |
| Moving Average: |
MA(5): 1.41 MA(20): 1.61
MA(100): 0.89 MA(250): 0.85 |
| MACD: |
MACD(12,26): 0.05 Signal(9): 0.13 |
| Stochastic oscillator: |
%K(14,3): 15.73 %D(3): 12.95 |
| RSI: |
RSI(14): 46.06 |
| 52-week: |
High: 5.52 Low: 0.47 Change(%): 12.6 |
| Average Vol(K): |
3-Month: 1786223 10-Days: 3185253 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.AIKI has closed above bottom band by 22.8%. Bollinger Bands are 210.3% wider than normal. The large width of the bands suggest high volatility as compared to AIKI's normal range. The bands have been in this wide range for 37 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 23 Feb 2021
Aikido Pharma Inc (AIKI) Stock Is Lower By -38.97% This Week: Buy, Hold, or Sell? - InvestorsObserver
Mon, 22 Feb 2021
AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus That Causes COVID-19 - Yahoo Finance
Fri, 19 Feb 2021
AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock - Yahoo Finance
Tue, 16 Feb 2021
AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment - PRNewswire
Tue, 16 Feb 2021
AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million - Yahoo Finance
Fri, 12 Feb 2021
Should You Buy Aikido Pharma Inc (AIKI) Stock Friday? - InvestorsObserver
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
35 |
| Shares Float (M) |
29 |
|
% Held by Insiders
|
5.62 |
|
% Held by Institutions
|
13.10 |
|
Shares Short (K)
|
1,150 |
|
Shares Short P. Month (K)
|
691 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-92677.78 |
|
Return on Assets (ttm)
|
-26.7 |
|
Return on Equity (ttm)
|
-61.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-4 |
|
Levered Free Cash Flow (M)
|
-7 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
5154.19 |
|
Price to Cash Flow
|
-10.62 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
1980-05-11 |
|
7 Binary Options
|
|
Your Ad Here
|
|
